PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Symptom | |cardiovascular disease |
| Sentences | 60 |
| PubMedID- 21071477 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. |
| PubMedID- 23079082 | Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations. |
| PubMedID- 26362702 | Risk factors for cardiovascular disease in rheumatoid arthritis patients from mato grosso do sul. |
| PubMedID- 21981268 | Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22808986 | Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 21345288 | Lack of association between retn rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 23899926 | Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22272574 | Influence of mhciita rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. |
| PubMedID- 20040642 | Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds. |
| PubMedID- 22657383 | Association of the methionine sulfoxide reductase a rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. |
Page: 1 2